Senior Manager Real World Analytics (Hybrid) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Vertex Pharmaceuticals · 1 day ago

Senior Manager Real World Analytics (Hybrid)

Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation. The Real World Analytics (RWA) Senior Manager leads the execution of statistical analysis plans for observational research and manages workload in support of therapeutic areas, requiring expertise in statistical programming and project management.

BiotechnologyHealth CareMedicalPharmaceutical
check
Growth Opportunities
check
H1B Sponsor Likelynote

Responsibilities

Executes on statistical analysis and programming plans. Ensure quality and timely deliverables for all assigned studies/projects
Advises on database selection, patient population selection and statistical analysis plans
Lead RWD analytics QC including training and enforcing SAS programming standards for Vertex relevant disease states across RWE
Tracks and archives RWA projects in accordance with department standards
Remains current on medical coding systems and relevant large healthcare databases; develops and maintains statistical programming skills
Actively participates in the identification, evaluation and prioritization of potential database acquisitions/licenses; Supports the vendor licensing and contracting processes
Supports staff with new software, programming techniques, and databases. Partners with Data, Technology and Engineering (DTE) to advance RWA technology competencies through the agile adoption of novel techniques, programming languages, and analytics
Provides data management support for RWE observational studies as needed

Qualification

Statistical programmingSAS programmingProject managementSQLPythonRData managementInfluence managementEpidemiology trainingAttention to detailCommunication skillsInterpersonal skillsLeadership skillsAdaptability

Required

PhD in biostatistics, epidemiology, health economics and outcomes research, health policy, or similar with minimum 1 -3 years statistical programming experience
Masters degree in Epidemiology, Public Health, Biostatistics or related field and 5-8 years statistical programming experience
Demonstrated experience with statistical programming and analysis of RWD including medical and pharmacy billing claims, electronic health records, disease registries, etc
Technical competence in efficient SAS programming methods and other relevant data analytics software and languages (e.g. SQL, Python, R)
Attention to detail is critical, as is adhering to standards and procedures
Good organizational and written/verbal communication skills required
Good interpersonal, leadership, and influence management skills are also important
Strong study and project management skills
Demonstrated ability to design and execute observational research, including data management experience with observational studies and/or clinical trials
Ability to work effectively in a constantly changing, diverse, and matrix environment
Formal training in Epidemiology/Health Services Research or related is required

Benefits

Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)

Company

Vertex Pharmaceuticals

company-logo
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

H1B Sponsorship

Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)

Funding

Current Stage
Public Company
Total Funding
$657.31M
Key Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M

Leadership Team

leader-logo
Reshma Kewalramani
CEO and President
linkedin
leader-logo
Nina Devlin
Senior Vice President, Chief Communications Officer
linkedin
Company data provided by crunchbase